The global cannula market size was valued at USD 204.22 million in 2025 and is projected to grow from USD 219.43 million in 2026 to USD 389.90 million by 2034, registering a CAGR of 7.45% during the forecast period from 2026 to 2034. North America dominated the cannula market with a market share of 38.5% in 2025.
A cannula is a thin, hollow medical tube designed to provide access to blood vessels, body cavities, or tissues for the administration or removal of fluids, medications, gases, or biological materials. Cannulas are commonly used for intravenous therapy, oxygen delivery, blood collection, drainage, and surgical procedures. They are available in different sizes, shapes, and materials depending on their intended clinical application.
Download a Free Sample To learn more about this report,
Growing Demand for Safer and Infection-Control-Focused Cannula Technologies
The cannula market trends are being driven by the widespread use of intravenous therapy, increasing hospital procedures, and stronger emphasis on patient safety and infection prevention. Peripheral intravenous cannulas are routinely used to administer fluids, medicines, blood products, and other therapies, making reliable and easy-to-use designs essential across hospitals and outpatient settings. Manufacturers are increasingly focusing on safety-engineered cannulas with needle-protection mechanisms, improved catheter materials, better insertion performance, and reduced risk of needlestick injuries. Demand is also growing for products that support lower infection risk and longer, clinically appropriate use. In May 2026, the World Health Organization released new global guidance covering central venous catheters and reinforcing the importance of aseptic insertion, maintenance, access, and removal practices. Earlier WHO guidance on peripheral intravenous catheters highlighted their widespread use across healthcare settings. These developments are encouraging healthcare facilities and manufacturers to place greater emphasis on standardized catheter care, safety features, and infection-control performance.
These developments indicate that safety-engineered designs, infection prevention, improved catheter materials, standardized clinical practices, and specialized vascular cannulas will remain the key cannula market trends, improving patient safety, supporting healthcare efficiency, and driving long-term demand across hospitals and clinical care settings.
Rising Number of Surgical Procedures and Growing Demand for Minimally Invasive Healthcare
The cannula market is expanding due to the increasing number of surgical, diagnostic, and therapeutic procedures requiring reliable access to blood vessels, body cavities, and targeted treatment sites. Cannulas are widely used in intravenous therapy, anesthesia, blood collection, cosmetic procedures, and minimally invasive surgeries, supporting their broad adoption across healthcare settings. Rising healthcare expenditure, increasing prevalence of chronic diseases, and growing preference for minimally invasive procedures are further accelerating demand. These developments are significantly contributing to cannula market growth as hospitals and clinics increasingly adopt specialized cannula products for efficient patient care.
Risk of Complications and High Costs of Specialized Cannulas
The cannula market faces challenges due to the risk of complications such as infection, bleeding, tissue damage, and improper placement, particularly when insertion and handling procedures are not performed correctly. Advanced cannulas designed for specialized surgical and therapeutic applications can also have higher costs than conventional products, affecting adoption in cost-sensitive healthcare facilities. Strict sterilization, quality control, and regulatory requirements further increase manufacturing and operational expenses. Recent cannula market analysis indicates that these factors can restrict market penetration, particularly in healthcare systems with limited resources.
Expansion of Specialized Cannulas and Advanced Material Technologies
The cannula market is expected to benefit from increasing demand for specialized cannulas used in minimally invasive surgery, cosmetic procedures, intravenous therapy, and advanced drug delivery applications. Manufacturers are developing products using biocompatible, flexible, and antimicrobial materials to improve patient comfort, reduce complications, and enhance procedural performance. Growing adoption of image-guided procedures and the development of application-specific cannula designs are also creating significant growth opportunities. These developments are expected to strengthen the cannula market size by expanding applications across hospitals, ambulatory surgical centers, specialty clinics, and home healthcare settings.
Ensuring Sterility, Patient Safety, and Consistent Product Performance
The cannula market continues to face challenges related to maintaining sterility, ensuring safe insertion, and achieving consistent product performance across different clinical applications. Manufacturers must meet stringent quality and regulatory requirements while producing cannulas with appropriate flexibility, strength, dimensional accuracy, and biocompatibility. Healthcare providers must also follow strict infection-control procedures to minimize risks associated with cannula use. According to recent cannula market reports, companies are investing in antimicrobial materials, precision manufacturing, safety-engineered designs, and improved quality-control systems to enhance product reliability and strengthen long-term market competitiveness.
Peripheral Cannula Segment is Projected to Register the Fastest Growth at a CAGR of 7.91%
The peripheral cannula segment is projected to register the fastest growth at a CAGR of 7.91% during 2026–2034. In 2025, the segment accounted for 31.8% of the global cannula market, with a value of USD 0.06 billion. Growth is driven by increasing use of peripheral cannulas for routine intravenous access, rising healthcare procedures, and growing demand for efficient and minimally invasive methods of fluid and medication administration. Expanding hospital and outpatient care continues to support the segment's growth.
The intravenous cannula segment dominated the market with a 54.6% share and a value of USD 0.11 billion, supported by its widespread use for intravenous fluid administration, medication delivery, and other clinical procedures. The nasal cannula segment accounted for 30.7% of the market, while the central line cannula segment represented 14.2%.
Draining cannulas accounted for 8.6% of the market, while other cannula products represented 14.7%. These products continue to support specialized clinical procedures across healthcare settings.
Request Customizationto receive a tailored report.
Oxygen Delivery Segment is Projected to Register the Fastest Growth at a CAGR of 7.86%
The oxygen delivery segment is projected to register the fastest growth at a CAGR of 7.86% during 2026–2034. In 2025, the segment accounted for 34.9% of the global cannula market, with a value of USD 0.07 billion. Growth is driven by increasing demand for respiratory support, rising prevalence of respiratory conditions, and growing use of cannulas for oxygen administration across hospitals, clinics, and other healthcare settings.
Anaesthesia and surgery accounted for 28.4% of the market, with a value of USD 0.06 billion. Administration of medicine represented 20.9% of the market, supported by the widespread use of cannulas for controlled medication delivery during healthcare procedures.
Blood sampling accounted for 15.8% of the market, with a value of USD 0.03 billion. Continued demand for efficient blood collection procedures supports the use of cannulas in relevant clinical applications.
22G Segment is Projected to Register the Fastest Growth at a CAGR of 7.96%
The 22G segment is projected to register the fastest growth at a CAGR of 7.96% during 2026–2034. In 2025, the segment accounted for 22.1% of the global cannula market, with a value of USD 0.05 billion. Growth is driven by increasing use of appropriate cannula sizes across clinical procedures, rising demand for patient-specific vascular access, and continued adoption in routine healthcare applications.
The 20G segment dominated the market with a 29.4% share and a value of USD 0.06 billion. The 18G segment accounted for 25.7% of the market, while the 14G segment represented 9.6%. These sizes continue to support different requirements for fluid administration and vascular access.
Other sizes accounted for 13.2% of the market, with a value of USD 0.03 billion. Their use across specialized procedures continues to contribute to overall market demand.
Plastic Segment is Projected to Register the Fastest Growth at a CAGR of 7.69%
The plastic segment is projected to register the fastest growth at a CAGR of 7.69% during 2026–2034. In 2025, the segment accounted for 62.8% of the global cannula market, with a value of USD 0.13 billion. Growth is driven by the widespread use of plastic cannulas, their suitability for disposable medical devices, and increasing demand for convenient and cost-effective cannula products across healthcare settings.
Stainless steel accounted for 24.6% of the market, with a value of USD 0.05 billion. Its continued use in specific medical applications is supported by its durability and established role in healthcare procedures.
Silicon represented 12.6% of the market, with a value of USD 0.03 billion. The material continues to support cannula applications where flexibility and material compatibility are important considerations.
Ambulatory Surgical Centres Segment is Projected to Register the Fastest Growth at a CAGR of 8.12%
The ambulatory surgical centres segment is projected to register the fastest growth at a CAGR of 8.12% during 2026–2034. In 2025, the segment accounted for 21.3% of the global cannula market, with a value of USD 0.04 billion. Growth is driven by the increasing shift toward outpatient procedures, expanding ambulatory surgical infrastructure, and rising demand for efficient medical devices during same-day surgical and procedural care.
Hospitals and clinics dominated the market with a 68.5% share and a value of USD 0.14 billion, supported by high procedure volumes, extensive patient care activities, and widespread use of cannulas for medication administration, fluid delivery, oxygen therapy, and other clinical procedures.
Other end users accounted for 10.2% of the market, with a value of USD 0.02 billion. This segment continues to contribute to demand through cannula applications across additional healthcare and clinical settings.c
Speak to an Analystto discuss market opportunities.
North America cannula market accounted for 38.5% of the global market, reaching USD 0.08 billion in 2025, and is projected to grow at a CAGR of 7.05% during the forecast period. The market is driven by increasing surgical and minimally invasive procedures, rising demand for cosmetic and medical applications, growing healthcare expenditure, and expanding adoption of advanced cannula technologies. Increasing demand across hospitals, specialty clinics, and aesthetic centers continues to support regional market growth.
The US market is supported by increasing surgical and aesthetic procedures, growing demand for minimally invasive treatments, rising healthcare expenditure, and expanding adoption of advanced cannula products across hospitals and specialty clinics.
Canada's market growth is driven by increasing healthcare investments, growing surgical procedures, rising demand for minimally invasive medical devices, and expanding adoption of cannula products across healthcare facilities.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe cannula market accounted for 27.2% of the global market, reaching USD 0.06 billion in 2025, and is projected to grow at a CAGR of 6.82% during the forecast period. Increasing surgical procedures, growing demand for minimally invasive treatments, rising healthcare expenditure, and expanding aesthetic medicine applications continue to strengthen regional market growth. Increasing adoption of advanced medical devices and growing healthcare infrastructure further support market expansion.
The UK market is supported by increasing demand for minimally invasive procedures, growing aesthetic medicine activities, rising surgical volumes, and expanding adoption of advanced cannula technologies across healthcare and specialty clinics.
Germany market growth is driven by strong healthcare infrastructure, increasing surgical procedures, growing demand for advanced medical devices, and rising adoption of minimally invasive technologies in hospitals and specialty healthcare facilities.
Asia Pacific cannula market accounted for 22.8% of the global market, reaching USD 0.05 billion in 2025, and is projected to grow at a CAGR of 8.96% during the forecast period. Rapid healthcare infrastructure development, increasing surgical procedures, rising medical expenditure, and growing adoption of minimally invasive treatments continue to accelerate regional market growth. Expanding aesthetic medicine and increasing demand for advanced medical devices further strengthen market expansion.
China's market is supported by expanding healthcare infrastructure, increasing surgical and aesthetic procedures, growing investments in medical technologies, and rising demand for minimally invasive medical devices.
Japan's market growth is driven by an aging population, increasing demand for surgical care, growing adoption of minimally invasive procedures, and rising investments in advanced healthcare and medical device technologies.
Middle East and Africa cannula market accounted for 5.1% of the global market, totaling USD 0.01 billion in 2025, and is projected to grow at a CAGR of 6.74% during the forecast period. Increasing healthcare infrastructure investments, growing surgical procedures, expanding aesthetic medicine activities, and rising demand for minimally invasive medical devices continue to support regional market growth.
The UAE market is supported by increasing investments in advanced healthcare facilities, growing medical tourism, rising demand for aesthetic and minimally invasive procedures, and expanding adoption of advanced medical devices.
Africa's market growth is supported by expanding healthcare infrastructure, increasing access to surgical care, growing investments in medical facilities, and rising demand for minimally invasive medical devices, creating long-term opportunities for cannula adoption across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Hemostasis & Tissue Sealing Agents Market Size, Share, 2034
Extremity Tissue Expanders Market Size, Share, Growth, Analysis, 2034
Vaginal Rejuvenation Market Size, Share, Growth, Analysis, 2034
Brachytherapy Market Size, Share, Growth, Analysis, Report, 2034
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com